Myelodysplastic Syndrome
8 competing products in clinical development for Myelodysplastic Syndrome.
Pipeline by Phase
Phase 12
Phase 26
All Products (8)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Decitabine + Decitabine + Decitabine | Eisai | Phase 2 | Completed | 35 |
| Decitabine + Valproic Acid | Eisai | Phase 2 | Completed | 35 |
| decitabine + decitabine | Eisai | Phase 2 | Completed | 35 |
| Decitabine, Arsenic Trioxide and Ascorbic Acid | Eisai | Phase 2 | Completed | 35 |
| Decitabine | Eisai | Phase 2 | Completed | 35 |
| decitabine + decitabine + decitabine + decitabine | Eisai | Phase 1 | Completed | 29 |
| Decitabine | Eisai | Phase 2 | Terminated | 27 |
| Subcutaneous Decitabine | Eisai | Phase 1 | Terminated | 21 |